Grants closing in September 2026

Funds fundamental (Basic) and Credentialing cancer research, including biological mechanisms of cancer onset/progression and psychosocial impacts. Open to Research Project, Consortium, and Unique High-Risk proposal types. Participating institutes must be registered in KWF GMS at least 6 weeks before closing. YIG proposals must be submitted under the separate 2026/YIG call.

Dedicated to basic research uncovering mechanisms driving cancer onset, growth, and spread. Intended for proposals within the Basic research and Credentialing phases. Aims to address knowledge gaps and identify new leads for prevention, diagnosis, and treatment.

Stipend of NOK 200,000 for physicians during PhD work or continuing research after PhD. Priority given to cancer in children and young people. May be used for international stays or equipment. Norwegian applicants.

Open to non-profit organisations and public institutions in Denmark, Greenland and Faroe Islands. Research institutions may be co-applicants but not lead applicants. Projects must integrate health promotion into social initiatives for vulnerable children aged 0–10. Applications may be submitted in Danish or English. Cross-sectoral partnership (health + social sector) required. Project start between 1 Jan–31 Dec 2027.

Open to postdoctoral researchers with a doctoral degree and <5 years of mentored research experience (M.D. applicants exclude residency years). Research must be in immunology or cancer immunology at a non-profit institution worldwide. No citizenship restrictions. Sponsor must hold assistant professor rank or higher. Only 1 fellow per sponsor per round.

Open to early-career scientists worldwide (<5 years mentored research post-PhD at award activation) at non-profit institutions. Supports dual training in cancer immunology and computational biology/data science. No citizenship restrictions. Must be conducted under a sponsor holding assistant professor or higher rank. Proposals must be hypothesis-driven in basic or translational cancer immunology.

Cancer research stipend of NOK 200,000 for medical doctors during PhD work or continuing research after PhD. Priority given to cancer in children and young people. May be used for international stays or equipment. Full call text at onkologiskforum.org.

Funds fundamental (Basic Research phase 1) and Credentialing (phase 2) cancer research, including biological mechanisms of cancer onset/progression and psychosocial impacts. Proposal types: Research Project, Consortium, and Unique High-Risk. Submitted via KWF GMS; participating institutes must register ≥6 weeks before closing. YIG proposals must use the separate 2026/YIG call.

Cancer research stipend (NOK 200,000) for medical doctors during PhD work or continuing research after PhD. Priority given to cancer in children and young people. May be used for international stays or equipment. Full call text at onkologiskforum.org.

Main applicant must be an established investigator with primary employment at a university, hospital, or non-profit research institution in a Nordic country (Denmark, Sweden, Norway, Finland, Iceland, Greenland, Faroe Islands). Translational/applied focus on regenerative medicine (stem cell-based therapies); fundamental discovery, adult immune cell (CAR-T/NK), and gene therapy projects are out of scope. For-profit partners may collaborate but cannot receive direct funding (subcontractors excepted).

For registered healthcare professionals (including doctors, nurses, AHPs, vets) who hold a PhD received ≥5 years ago and wish to reacquire research skills. Fellowship must be hosted at an eligible UK research organisation; international applicants must hold or obtain UK regulatory body registration. Funded at 80% FEC. Jointly funded options available with named charities. Applicant must intend to be clinically active in the UK during or after the award.

Open to registered healthcare professionals (doctors, nurses, vets, etc.) of any nationality, but fellowship must be hosted at an eligible UK research organisation. Applicants must hold a completed PhD or equivalent (before award start). Must not have previously secured independence via grants leading research staff. Fellowship must be based full-time at host; clinical sessions up to 4/week permitted for relevant specialties. Joint funding available with several charities (e.g. Diabetes UK, Parkinson's UK).

Supports STEM education, science pedagogy research, and informal science/technology learning for children, youth, and the general public in the Danish realm. Administering institution must be a public institution or non-profit org (incl. schools, municipalities, research institutions, museums, associations) in Denmark. Proposals in Danish or English. Research projects must be anchored at a Danish university or university college.

Supports projects innovating, implementing and/or scaling up sustainable behaviour and practices among individuals, communities, and organisations in Denmark. Host institution must be based in Denmark. Up to DKK 6M for projects up to 3 years.

Project grants (DKK 100k–6.6M) to strengthen STEM teaching quality in Danish vocational and professional education (EUD/EUX, erhvervsakademi, professionsbachelor) within sustainability and health. Administering institution must be a public or non-profit organisation in the Danish realm (Denmark, Greenland, Faroe Islands). Proposals in Danish or English. Pure research projects and research fellowships are excluded.

Supports creative, high-risk/high-gain interdisciplinary research spanning scientific disciplines and techniques, addressing challenges in health and sustainability. Applicants must be based in Denmark. Focuses on early-stage, untested ideas requiring interdisciplinary collaboration across disciplines, organisations, and national borders.

Fundamental research in natural and technical sciences (physics, chemistry, mathematics, computer science, engineering) with potential applications in life science, health or sustainability. PI must have ≥80% affiliation to a Danish university or non-profit research institution; applicant's own salary must be covered from other sources. PhD student applications not accepted. Call opens 19 June 2026.

Amorçage de jeunes équipes 2026 - Session 2 (Programme généraliste) — funding call from France's Fondation pour la Recherche Médicale (FRM), the country's leading private biomedical-research foundation. Open to researchers at French host institutions across all areas of biology, medicine and health.

Funds research on prevention and management of nutrition-related cardiometabolic diseases (CMDs) and translation of nutritional science into society. Supports science capital in Denmark within nutritional sciences. Budget increases to DKK 5M if project includes an international co-applicant. Eligibility details in chunk 2.

Bilateral Sweden–Italy collaboration grant in quantum and solar technologies. Swedish applicants must partner with Italian counterparts. Opens 24 June 2026; deadline 8 September 2026.

For senior researchers at the consolidation/leadership stage who obtained their PhD within 15 years before 1 March 2026 (extensions possible). Applicants must demonstrate that Vici will substantially contribute to consolidating their research group. Proposals must be written in English. Hosted at Dutch knowledge institutions via ZonMw/NWO.

Funds clinical research (Proof of Concept or Clinical Validation studies) into drug repurposing of existing off-patent medicines for ME/CFS patients in the Netherlands. Applicants must be Dutch legal entities (public or private law). Non-research organisations must provide ≥50% co-financing. Proposals must be submitted in English via My ZonMw.

Open to UK research groups and individuals (any career stage, subject to NERC eligibility). Focuses on aviation non-CO2 climate impacts across three themes: contrail/aerosol prediction confidence, future fuels (SAF, hydrogen, fuel cells), and decision-making support. Projects with industrial partnerships encouraged. Up to 6 projects funded; projects must start no later than 1 February 2027. UK host institution required.

Open to postdoctoral researchers of any nationality with max 8 years post-PhD experience. European Fellowships require a host in an EU/associated country; Global Fellowships require EU/associated country nationals or long-term residents working in a third country then returning to Europe. Researchers must not have resided in the host country for more than 12 months in the last 3 years (standard MSCA mobility rule). Open to all scientific fields including Euratom research.

Postdoctoral fellowships for researchers of any nationality hosted at institutions in EU Member States or Associated Countries. Researchers must hold a PhD and have ≤8 years full-time research experience at the deadline. MSCA mobility rules apply: applicants cannot have resided in the host country for >12 months in the 3 years prior to the deadline. Full-time commitment required as a rule.

Global Fellowships for nationals or long-term residents of EU Member States or Associated Countries, involving an outgoing phase at a non-EU/Associated Country partner and a mandatory return phase. Researchers must hold a PhD and have ≤8 years full-time research experience. MSCA mobility rules apply to both outgoing and return phases. Full-time commitment required as a rule.

Postdoctoral fellowships for researchers of any nationality hosted at EU Member State or Associated Country institutions. Researchers must have a PhD and ≤8 years full-time research experience at deadline. Mobility rule applies: applicants cannot have resided/worked in the host country for >12 months in the 3 years before the deadline. Full-time employment required as a rule.

Global Fellowships for nationals or long-term residents of EU Member States or Associated Countries, involving an outgoing phase at a non-EU/Associated Country host and a mandatory return phase. Researchers must have a PhD and ≤8 years full-time research experience at deadline. Mobility rule applies. Full-time employment required as a rule.

Postdoctoral researchers of any nationality, max 8 years full-time research experience post-PhD at deadline. Mobility rule applies: researcher must not have resided/worked in the host country for >12 months in the 3 years before deadline. Full-time commitment required. Host must be an eligible organisation in an EU Member State or Horizon Europe Associated Country.

Restricted to nationals or long-term residents of EU Member States or Horizon Europe Associated Countries, max 8 years post-PhD. Outgoing phase at a non-EU/non-Associated Country organisation, with mandatory return phase to an EU/Associated Country host. Full-time commitment required; mobility rules apply.

Open to PhD holders of any nationality. European Fellowships: mobility to/within EU Member States or Horizon Europe Associated Countries. Global Fellowships: EU nationals or long-term residents, outgoing phase in non-associated Third Country + mandatory 12-month return phase to EU/Associated Country host. Applications submitted jointly by researcher and academic or non-academic host organisation. Specific Euratom conditions apply for nuclear research areas.

Open to postdoctoral researchers of any nationality with max 8 years post-PhD experience. European Fellowships: host in EU/Horizon Europe associated country. Global Fellowships: EU/associated country nationals or long-term residents, outgoing to third country then returning to Europe. Host organisations can be universities, research institutions, companies, SMEs, hospitals, NGOs, or public bodies. ERA Fellowship opt-in available for widening-country hosts.

Open to PhD holders of any nationality. European Fellowships: any nationality, hosted in EU/Associated Country. Global Fellowships: European nationals or long-term residents, outgoing phase at a non-associated Third Country (e.g. Canada) + mandatory 12-month return phase to EU/Associated Country host. Supports international, interdisciplinary, and inter-sectoral mobility including non-academic sector, reintegration, displaced researchers, and career-restart cases.

Promotes broad research collaboration between Norwegian research communities and societal/business actors on seabed mineral activities and environmental consequences. Norwegian research organisations eligible.

Funds projects developing technology and solutions for energy efficiency and energy transition in buildings, areas and industry, including surplus heat utilisation, local power production, and fossil fuel transition.

Supports group leaders to develop their research programme and build reputation as world-leaders in cancer research. Eligibility criteria changed: no longer accepting new outline applications from clinicians following the May 2026 committee review.

Supports new group leaders who do not have a salaried independent position to establish their independent research group in cancer research.

Supports clinician scientists to transition to research independence and leadership in cancer research. Restricted to clinician scientists; host organisation must contribute towards the fellow's salary.

Supports clinician scientists who have gained a higher research degree and some postdoctoral experience, ready to develop their own research niche. Restricted to clinician scientists.

UK academic researchers embedded in government host departments for 18 months to support evidence-informed policymaking. Applicants must hold a doctorate or equivalent research experience. Fellowship starts 1 May 2027. Early-career researchers receive funded mentorship. Minimum 0.6 FTE during placement. Includes £15,000 mandatory flexible budget.

UK academic researchers embedded in government host departments focusing on natural hazards and resilience. Includes an additional £100,000 research and collaboration budget co-funded by DCMS. Applicants must hold a doctorate or equivalent. Fellowship starts 1 May 2027. Minimum 0.6 FTE during placement. Includes £15,000 mandatory flexible budget.

UK academic researchers embedded in What Works Network host organisations for 18 months. Includes an additional £40,000 research and collaboration budget for co-production and collaboration. Applicants must hold a doctorate or equivalent. Fellowship starts 1 May 2027. Minimum 0.6 FTE during placement. Includes £15,000 mandatory flexible budget.

Invited full applications for MRC Centres of Research Excellence (CoRE) addressing a defined long-term biomedical or health research challenge over 14 years. Open to UK research organisations; lead applicant must be affiliated with the lead research organisation. Requires standard 20% FEC; no additional matched funding required. International project co-leads permitted. Ministry of Defence participates in assessment.

Supports new group leaders who have a salaried independent position to establish their independent research group. Eligibility changed: no longer accepting new outline applications from clinicians following May 2026 committee review.

Open to researchers holding a doctorate or equivalent research experience, based at a UK research organisation (lead organisation must submit). Fellows undertake an 18-month policy fellowship with a UK government host, starting 1 May 2027. Three fellowship tracks: Core (up to £180k FEC), What Works Innovation (up to £220k FEC), and Natural Hazards and Resilience (up to £280k FEC, co-funded by DCMS). Early-career researchers receive funded mentorship support.

Upcoming call opening 19 August 2026. International postdoctoral fellowship for researchers in humanities, social sciences, and educational sciences. Mobility grant requiring postdoc to be conducted abroad; applicants must be affiliated with a Swedish institution.

Horizon Europe RIA under the EU Cancer Mission supporting development of validated microbiome tools for early cancer prediction before disease onset, including AI risk modelling, longitudinal cohort studies, and comparison with liquid biopsy tests. Proposals must address multiple cancer types where possible and collaborate with large cohorts/registries. Lump sum grant; one grant expected.

Allocates national HPC, AI, and Scientific Cloud Computing resources (Deucalion, Cirrus+Stratus, MareNostrum 5). A0: experimental access (6 months, up to 50,000 CPU core.hours / 500 GPU.hours); A1: development access (3–12 months, up to 100,000 CPU core.hours / 5,000 GPU.hours). Eligible: Portuguese R&D institutions, collaborative labs, tech-interface centres, digital innovation hubs, non-profits, and companies/individuals active in Portugal. Applications must be submitted in English via myFCT platform.

Advanced computing access (HPC, AI, Cloud) for teams with no prior RNCA experience. Proposals must be submitted in English via myFCT. Max 50,000 CPU core-hours and 500 GPU-hours per project. Eligible applicants include R&D institutions, companies (pre-competitive R&D only), and individuals active in Portugal. Fast-track (via rápida) requires prior scientific evaluation in the last 3 years.

Supports exploratory applied research on testable and existing AI applications (use cases) focused on labour-saving AI. Conducted through new practice-oriented research activities at universities of applied sciences.

Open to consortia of 3–12 researchers from all scientific disciplines (including art-based basic research) at one or more Austrian research institutions. Supports collaborative research projects; both small and large teams eligible. Full eligibility and budget details not yet visible in this page segment.

Horizon Europe RIA under the Cancer Mission calling for development of advanced multiscale Virtual Human Twin (VHT) models integrating AI and multimodal patient data to understand cancer onset/progression and personalise treatments. Proposals must include multidisciplinary consortia (medical, AI, patient representatives, SMEs) and share data/models via UNCAN.eu and the Advanced VHT Platform under open science principles. Clinical studies may be included with a dedicated annex.

Upcoming call opening 19 August 2026. International postdoctoral fellowship for researchers in natural and engineering sciences. Mobility grant requiring postdoc to be conducted abroad; applicants must be affiliated with a Swedish institution.

International postdoctoral fellowship for early-career researchers in medicine and health. Supports postdocs at foreign host institutions. Applicants must be affiliated with Swedish research institutions. Call opens 19 August 2026.

Horizon Europe RIA (lump sum) for academic investigator-initiated pragmatic clinical trials on immunotherapeutic interventions for refractory cancer patients. Proposals must include a clinical studies annex, disaggregate data by sex/gender/age, and engage patients in endpoint definition. Applicants must include diverse stakeholders and plan to join the EU Cancer Mission 'Diagnosis and Treatment' cluster. ~3 grants expected.

Horizon Europe RIA under the EU Cancer Mission call HORIZON-MISS-2026-02. One indicative grant of approximately €15M. Full topic description available in the Work Programme. Consortia must include eligible entities from at least 3 EU member states or associated countries.

Horizon Europe Innovation Action under the EU Cancer Mission call HORIZON-MISS-2026-02. One indicative grant of approximately €7M. Full topic description available in the Work Programme. Consortia must include eligible entities from at least 3 EU member states or associated countries.

Horizon Europe Coordination and Support Action under the EU Cancer Mission call HORIZON-MISS-2026-02. One indicative grant of approximately €5M. Full topic description available in the Work Programme. Consortia must include eligible entities from at least 3 EU member states or associated countries.

Horizon Europe Research and Innovation Action under the Cancer Mission 2026 call. Single grant expected at approximately €15M. Full topic description available in the call portal.

Horizon Europe RIA under the Cancer Mission. Requires development of multiscale AI-integrated Virtual Human Twins for cancer onset, progression and personalised treatment. Proposals must include clinical study annex if clinical studies are envisaged. Interdisciplinary consortia including healthcare professionals, patient representatives, AI experts and SMEs expected. Open science principles mandatory; data must be shared via UNCAN.eu and Advanced VHT Platform.

Horizon Europe RIA under the Cancer Mission (Supporting the implementation of the Cancer Mission call HORIZON-MISS-2026-02). Single grant expected. Full topic description available in the call portal.

Allocates national HPC, AI, and Scientific Cloud Computing resources (Deucalion, Cirrus+Stratus, MareNostrum 5). A0 = Experimental Access (6 months, max 50,000 CPU core.hours / 500 GPU.hours); A1 = Development Access (3–12 months, max 100,000 CPU core.hours / 5,000 GPU.hours). Eligible: Portuguese R&D institutions, collaborative labs, tech-interface centres, companies (pre-competitive R&D only, ≤50% of total quota), and individuals active in Portugal. Applications must be submitted in English via myFCT platform.

For researchers post-PhD seeking first step to independence in MRC remit (human health). Must be hosted at an eligible UK research organisation; applicants of all nationalities welcome. Clinically active researchers are ineligible (separate clinician scientist scheme). Cannot hold a comparable fellowship or have secured grants as project lead with research staff. Fellowship must be full-time (or part-time for personal reasons only). Start date June–September 2027.

Supports strategic recruitment of associate senior lecturers (early-career faculty) at Swedish higher education institutions. Organisation applicants. Opens 19 August 2026; deadline 15 September 2026.

Funds dissemination and communication activities within artistic research. Opens 19 August 2026; deadline 15 September 2026.

Funds exploratory workshops in the field of artistic research. Applicants must be based at Swedish research institutions. Call opens 19 August 2026.

Main applicant must be affiliated ≥80% FTE with a Danish university, hospital, or non-profit organisation. 1–2 co-applicants required (domestic or international non-profit). At least one party must have expertise in synchrotron-based crystallography. Projects must fall within biomedicine, health, sustainability, biotechnology, natural/technical, or data science; non-health/sustainability science must describe potential future applications in those areas.

European Partnership on Animal Health and Welfare call covering Topic 1 (Animal Welfare) and Topic 2 (Prevention & Control). International joint call requiring transnational consortia.

Supports novel, ambitious, transformative arts and humanities research teams (3–5 years, £2M–£3M FEC; AHRC funds 80%). Must be team-convened with distributed co-lead leadership. Lead research organisation must have standard UKRI eligibility (UK-based). International co-leads eligible up to 30% FEC. No PhD studentships permitted. Proposals must fall within AHRC subject remit.

Supports new and pioneering research ideas and pilot studies of high scientific risk to stimulate and develop the early cancer detection and diagnosis field.

Open to STFC-accredited UK universities and research organisations wishing to host one of five named core summer schools (Introductory Astronomy, BUSSTEPP, Solar/Solar-Terrestrial Physics, HEP, Nuclear Physics UK) in 2027. Schools must target STFC-funded PhD students and align with STFC's core science programme. Cost-per-student target below £150/day; specific caps apply to lecturer fees, accommodation, and conference dinner.

Prix & récompenses (Awards) in oncology research. Category is prizes/awards — included as it may carry a funded research component. Open call with deadline 21 September 2026.

Health~Holland PPP programme focused on lead-212 (Pb-212) radiopharmaceuticals for cancer treatment. Two pillars: (1) Pb-212 production & supply chain; (2) enabling technologies for clinical introduction. Proposals must include a private party (not in financial difficulty) and comply with Health~Holland PPP requirements. Consortium Agreement required. Submission via KWF GMS; unregistered institutes must register ≥6 weeks before deadline.

Add-on to an ongoing or recently completed KWF-funded project (incl. KWF-PPP, TTW Technology for Oncology, KWF-NWO early detection). Innovation must be at TRL ≥3. Applicants must collaborate with their institution's TTO. Supports translational pathway definition, limited development/validation, and regulatory/implementation preparation. Dutch research institutions only (KWF-funded projects).

Supports translation of KWF-funded innovations toward real-world application. Eligible only for ongoing or recently completed KWF projects (up to 1 year after completion). Covers steps such as external expertise, regulatory preparation, or business case development.

Add-on funding for ongoing or recently completed KWF-funded projects (incl. KWF-PPP, TTW Technology for Oncology, KWF-NWO early detection) that have reached at least TRL 3. Supports translational pathway definition, targeted development/validation, and regulatory/implementation preparation. TTO commitment letter mandatory; collaboration with TTO of applicant's research institution required.

For established researchers or teams (2–8 applicants) pursuing bold, creative research to deliver significant shifts in understanding related to human life, health and wellbeing. Lead applicant must be based at a not-for-profit organisation (HEI, research institute, healthcare org, or charity) in the UK, Republic of Ireland, or an eligible LMIC (excl. India and mainland China). No salary for lead applicant unless LMIC-based.

PPP proposals for lead-212 production/supply chain or enabling technologies for clinical introduction of Pb-212 radiopharmaceuticals. Requires active private-party participation (Health~Holland PPP rules), a Consortium Agreement, and compliance with RVO 'no undertaking in difficulty' declaration. Dutch-language summary required for patient advisory review. Netherlands-based institutions; unregistered institutes must register in KWF GMS ≥6 weeks before deadline.

Public-private partnership (PPP) call under Health~Holland for development of lead-212 production technology and enabling technologies for clinical radiopharmaceutical application. Proposals must include a private party (not an undertaking in difficulty) and comply with Health~Holland PPP requirements. Dutch Summary required for Patient Advisory Committee review. Participating institutes not yet registered must request access at least 6 weeks before closing.

Health~Holland PPP call for 1–6 projects on enabling technologies for safe clinical use of Pb-212 radiopharmaceuticals (chelators, radiobiology, dosimetry, QC, hospital infrastructure). Requires a public-private consortium with signed Consortium Agreement and Health~Holland PPP compliance. Private party must not be an undertaking in difficulty (RVO declaration required). Clinical/patient-sample context likely.

Open to researchers at eligible organisations globally; lead applicant salary not covered unless based in a low- or middle-income country with a permanent/long-term contract requiring external salary recovery. Applications managed in English. Covers discovery research across a broad range of disciplines including sciences, arts, humanities, and social sciences.

Health~Holland PPP call for development of lead-212 production/supply chain and enabling technologies for clinical radiopharmaceutical use. Proposals must include a private party (not in financial difficulty) and comply with Health~Holland PPP requirements. Dutch-language summary required for Patient Advisory Committee review. Institutions not yet registered in KWF GMS must apply at least 6 weeks before closing date.

Health~Holland PPP call for radiopharmaceutical research on lead-212 (alpha-emitting isotope) for cancer treatment. Two pillars: (1) Pb-212 production & supply chain; (2) enabling technologies for clinical introduction. Proposals must include a private-party partner not in financial difficulty (RVO declaration required). Dutch Summary reviewed by Patient Advisory Committee. Institutes not yet registered in KWF GMS must apply at least 6 weeks before closing.

Establishes up to three new Centres for Environment-friendly Energy Research (FME Society) focused on social science and humanistic perspectives for the energy transition. Approved Norwegian research organisations eligible.

Establishes up to two new research centres for petroleum (PETROSENTER) for long-term, targeted research at high international level. Approved Norwegian research organisations eligible.

For postdoctoral researchers with a PhD in a biological discipline. Must change country, not work in country of nationality or PhD, and not have spent >12 months in host country. PhD conferred after 24 Sep 2023. 100% FTE commitment required. For-profit host institutions ineligible. Frontier, interdisciplinary basic life-sciences research only; clinical/applied projects excluded.